Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol vs Nebivolol in Healthy Subjects (BINEB)
NCT04432610Phase 4Withdrawn
- Sponsor
- Clinical Hospital Center Zemun
- Start
- Jan 2030
- Primary completion
- Dec 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bisoprolol, nebivolol in hypertension (HTN), heart failure (HF), sponsored by Clinical Hospital Center Zemun. Planned start Jan 2030; status: withdrawn.
02
Drugs
bisoprololnebivolol
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT04432610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432610.